CD163 and neoplasm: For immunohistochemistry to detect components of the tumor microenvironment, we analyzed the distributions of PD-L1, markers of tumor-associated fibroblasts (SMA), markers of TAMs (CD163 and CD68), in the tumor and adjacent normal tissue.